Literature DB >> 19187398

FXYD1, a modulator of Na,K-ATPase activity, facilitates female sexual development by maintaining gonadotrophin-releasing hormone neuronal excitability.

C Garcia-Rudaz1, V Deng, V Matagne, O K Ronnekleiv, M Bosch, V Han, A K Percy, S R Ojeda.   

Abstract

The excitatory tone to gonadotrophin-releasing hormone (GnRH) neurones is a critical component underlying the pubertal increase in GnRH secretion. However, the homeostatic mechanisms modulating the response of GnRH neurones to excitatory inputs remain poorly understood. A basic mechanism of neuronal homeostasis is the Na(+),K(+)-ATPase-dependent restoration of Na(+) and K(+) transmembrane gradients after neuronal excitation. This activity is reduced in a mouse model of Rett syndrome (RTT), a neurodevelopmental disorder in which expression of FXYD1, a modulator of Na(+),K(+)-ATPase activity, is increased. We now report that the initiation, but not the completion of puberty, is advanced in girls with RTT, and that, in rodents, FXYD1 may contribute to the neuroendocrine regulation of female puberty by modulating GnRH neuronal excitability. Fxyd1 mRNA abundance reaches maximal levels in the female rat hypothalamus by the fourth postnatal week of life (i.e., around the time when the mode of GnRH secretion acquires an adult pattern of release). Although Fxyd1 mRNA expression is low in the hypothalamus, approximately 50% of GnRH neurones contain Fxyd1 transcripts. Whole-cell patch recording of GnRH-EGFP neurones revealed that the neurones of Fxyd1-null female mice respond to somatic current injections with a lower number of action potentials than wild-type cells. Both the age at vaginal opening and at first oestrous were delayed in Fxyd1(-/-) mice, but adult reproductive capacity was normal. These results suggest that FXYD1 contributes to facilitating the advent of puberty by maintaining GnRH neuronal excitability to incoming transsynaptic stimulatory inputs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19187398      PMCID: PMC2934895          DOI: 10.1111/j.1365-2826.2008.01812.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  52 in total

1.  Genetic targeting of green fluorescent protein to gonadotropin-releasing hormone neurons: characterization of whole-cell electrophysiological properties and morphology.

Authors:  K J Suter; W J Song; T L Sampson; J P Wuarin; J T Saunders; F E Dudek; S M Moenter
Journal:  Endocrinology       Date:  2000-01       Impact factor: 4.736

2.  The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression.

Authors:  K J Sweadner; E Rael
Journal:  Genomics       Date:  2000-08-15       Impact factor: 5.736

3.  Long-lasting increases in intrinsic excitability triggered by inhibition.

Authors:  Alexandra B Nelson; Claudia M Krispel; Chris Sekirnjak; Sascha du Lac
Journal:  Neuron       Date:  2003-10-30       Impact factor: 17.173

4.  Neuroendocrine control of the onset of puberty: secretion of gonadotrophin-releasing hormone from rat hypothalamic explants.

Authors:  J P Bourguignon; A Gerard; L Fawe; M L Alvarez-Gonzalez; P Franchimont
Journal:  Acta Paediatr Scand Suppl       Date:  1991

5.  A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.

Authors:  J Guy; B Hendrich; M Holmes; J E Martin; A Bird
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

6.  Hypertrophy, increased ejection fraction, and reduced Na-K-ATPase activity in phospholemman-deficient mice.

Authors:  Li-Guo Jia; Claudia Donnet; Roberta C Bogaev; Rebecca J Blatt; Cindy E McKinney; Kathleen H Day; Stuart S Berr; Larry R Jones; J Randall Moorman; Kathleen J Sweadner; Amy L Tucker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-11-24       Impact factor: 4.733

7.  A contactin-receptor-like protein tyrosine phosphatase beta complex mediates adhesive communication between astroglial cells and gonadotrophin-releasing hormone neurones.

Authors:  A-S Parent; A E Mungenast; A Lomniczi; U S Sandau; E Peles; M A Bosch; O K Rønnekleiv; S R Ojeda
Journal:  J Neuroendocrinol       Date:  2007-11       Impact factor: 3.627

8.  Glutamatergic signaling through the N-methyl-D-aspartate receptor directly activates medial subpopulations of luteinizing hormone-releasing hormone (LHRH) neurons, but does not appear to mediate the effects of estradiol on LHRH gene expression.

Authors:  Erich N Ottem; Jonathan G Godwin; Sandra L Petersen
Journal:  Endocrinology       Date:  2002-12       Impact factor: 4.736

9.  Neurotrophins and the neuroendocrine brain: different neurotrophins sustain anatomically and functionally segregated subsets of hypothalamic dopaminergic neurons.

Authors:  K Berg-von der Emde; W L Dees; J K Hiney; D F Hill; G A Dissen; M E Costa; M Moholt-Siebert; S R Ojeda
Journal:  J Neurosci       Date:  1995-06       Impact factor: 6.167

10.  MeCP2, a key contributor to neurological disease, activates and represses transcription.

Authors:  Maria Chahrour; Sung Yun Jung; Chad Shaw; Xiaobo Zhou; Stephen T C Wong; Jun Qin; Huda Y Zoghbi
Journal:  Science       Date:  2008-05-30       Impact factor: 47.728

View more
  10 in total

Review 1.  A system biology approach to identify regulatory pathways underlying the neuroendocrine control of female puberty in rats and nonhuman primates.

Authors:  Alejandro Lomniczi; Hollis Wright; Juan Manuel Castellano; Kemal Sonmez; Sergio R Ojeda
Journal:  Horm Behav       Date:  2013-07       Impact factor: 3.587

2.  Gene networks and the neuroendocrine regulation of puberty.

Authors:  Sergio R Ojeda; Christopher Dubay; Alejandro Lomniczi; Gabi Kaidar; Valerie Matagne; Ursula S Sandau; Gregory A Dissen
Journal:  Mol Cell Endocrinol       Date:  2009-12-22       Impact factor: 4.102

3.  Cell-specific mRNA alterations in Na+, K+-ATPase α and β isoforms and FXYD in mice treated chronically with carbamazepine, an anti-bipolar drug.

Authors:  Baoman Li; Leif Hertz; Liang Peng
Journal:  Neurochem Res       Date:  2013-02-10       Impact factor: 3.996

4.  Longitudinal course of epilepsy in Rett syndrome and related disorders.

Authors:  Daniel C Tarquinio; Wei Hou; Anne Berg; Walter E Kaufmann; Jane B Lane; Steven A Skinner; Kathleen J Motil; Jeffrey L Neul; Alan K Percy; Daniel G Glaze
Journal:  Brain       Date:  2016-12-21       Impact factor: 13.501

Review 5.  The transcriptional control of female puberty.

Authors:  Sergio R Ojeda; Alejandro Lomniczi; Alberto Loche; Valerie Matagne; Gabi Kaidar; Ursula S Sandau; Gregory A Dissen
Journal:  Brain Res       Date:  2010-09-17       Impact factor: 3.252

6.  Brain region-specific expression of Fxyd1, an Mecp2 target gene, is regulated by epigenetic mechanisms.

Authors:  Fatima Banine; Valerie Matagne; Larry S Sherman; Sergio R Ojeda
Journal:  J Neurosci Res       Date:  2011-03-10       Impact factor: 4.164

7.  Correcting deregulated Fxyd1 expression rescues deficits in neuronal arborization and potassium homeostasis in MeCP2 deficient male mice.

Authors:  Valerie Matagne; Joyce Wondolowski; Matthew Frerking; Mohammad Shahidullah; Nicholas A Delamere; Ursula S Sandau; Sarojini Budden; Sergio R Ojeda
Journal:  Brain Res       Date:  2018-06-12       Impact factor: 3.252

8.  Correcting deregulated Fxyd1 expression ameliorates a behavioral impairment in a mouse model of Rett syndrome.

Authors:  Valerie Matagne; Sarojini Budden; Sergio R Ojeda; Jacob Raber
Journal:  Brain Res       Date:  2012-12-14       Impact factor: 3.252

9.  Pubertal development in Rett syndrome deviates from typical females.

Authors:  John T Killian; Jane B Lane; Gary R Cutter; Steven A Skinner; Walter E Kaufmann; Daniel C Tarquinio; Daniel G Glaze; Kathleen J Motil; Jeffrey L Neul; Alan K Percy
Journal:  Pediatr Neurol       Date:  2014-08-29       Impact factor: 3.372

Review 10.  The mystery of puberty initiation: genetics and epigenetics of idiopathic central precocious puberty (ICPP).

Authors:  Sofia Leka-Emiri; George P Chrousos; Christina Kanaka-Gantenbein
Journal:  J Endocrinol Invest       Date:  2017-03-01       Impact factor: 5.467

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.